A potent tetravalent T-cell–engaging bispecific antibody against CD33 in acute myeloid leukemia

Abstract: Acute myeloid leukemia (AML), the most common acute leukemia in adults and the second most common cancer in children, is still a lethal disease in the majority of patients, but immunologic approaches have improved outcome. Bispecific antibodies (BsAbs) are novel immunotherapeutics that can...

Full description

Bibliographic Details

Published in:	Blood Advances
Main Authors:	Sayed Shahabuddin Hoseini, Hongfen Guo, Zhihao Wu, Miho Nakajima Hatano, Nai-Kong V. Cheung
Format:	Article
Language:	English
Published:	Elsevier 2018-06-01
Online Access:	http://www.sciencedirect.com/science/article/pii/S247395292030985X